Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Photodynamic Therapy Market?

In recent times, the photodynamic therapy market has experienced a remarkable expansion. The market, which is predicted to increase from $1.45 billion in 2024 to $1.53 billion in 2025, has a compound annual growth rate (CAGR) of 5.6%. The grow during the historic period is due to multiple factors. These include the growing number of older adults, a rise in cancer cases, an upsurge in skin diseases, increasing rates of pollution, a surge in healthcare spending, and the expansion of healthcare facilities.

Expectations for the photodynamic therapy market predict substantial growth in the coming years, projected to reach “$1.93 billion in 2029 at a 6.0% compound annual growth rate (CAGR). This growth during the projected timeframe can be credited to factors such as increased healthcare spending, photodynamic therapy insurance coverage, untapped potential in developing economies, growing teenage and elderly populations, a rise in cancer and chronic disease prevalence, and the emerging threat of infectious diseases. Key emerging trends during this period are anticipated to include the launch of portable devices for home-based dermatological photodynamic therapy, investment in AI-powered photodynamic therapy to enhance patient outcomes, broadening of the product range for cosmetic procedures, ongoing funding for research and development, distribution of photoimmunotherapy devices and the inclusion of photothermal therapy in the product line-up.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5246&type=smp

Which Growth Drivers Are Shaping The Photodynamic Therapy Market Outlook?

The photodynamic therapy market is witnessing expansion due to the escalating incidence of skin cancer. Skin cancer tops the list of the most frequent forms of cancer. Despite accounting for just 1% of skin cancers, melanoma is responsible for a significant proportion of fatalities related to skin cancer. Photodynamic therapy (PDT) which incorporates a light-sensitizing medicine and high-intensity light to eliminate cancer cells, is used in response to this. By applying a lotion containing a chemical that sensitizes light onto the skin cancer along with the neighbouring area, doctors take action against this malady. Illustratively, data from the American Cancer Society in January 2024, a professional entity based in the U.S., indicated that skin cancer is the most common type of cancer there, with melanoma making up about 1% of cases but causing most skin cancer-related deaths. Furthermore, in 2024, it is estimated that around 100,640 fresh melanoma instances will be detected in the U.S, which comprises approximately 59,170 men and 41,470 women. An estimated 8,290 individuals, including roughly 5,430 males and 2,860 females, are predicted to die from melanoma. Hence, the growing prevalence of skin cancer is anticipated to boost the photodynamic therapy market’s growth in the forthcoming years.

Which Segments Define The Structure Of The Photodynamic Therapy Market?

The photodynamic therapy market covered in this report is segmented –

1) By Product: Drugs, Devices

2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications

3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Drugs: Photosensitizers, Combination Drug Therapies, Novel Photosensitizer Formulations

2) By Devices: Light Sources (Laser Systems, LED Systems), Delivery Devices (Fiber Optics, Handheld Devices), Treatment Systems (Portable Devices, Fixed Systems)

What Strategic Shifts And Innovations Are Influencing The Photodynamic Therapy Market?

In the industry of photodynamic therapy, an increased focus has been observed on clinical trials for PDT in tandem with various drugs. For example, Kintara Therapeutics, a biotechnology firm based in the US, declared the initiation of a clinical trial for its REM-001 therapy aimed at cutaneous metastatic breast cancer in February 2024. With the clinical trial labeled NCT05374915, it’s an open-label study, working with 15 patients having cutaneous metastatic breast cancer (CMBC). The trial is set to evaluate the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The aim of the trial is to perfect the study structure for a forthcoming Phase 3 trial and to focus on the Best Overall Objective Response Rate (bORR) within treatment areas within the span of 24 weeks. The chief endpoint comprises both complete and partial responses measurement.

Which Firms Are Making The Biggest Impact In The Photodynamic Therapy Market?

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Indústria e Comércio de ProdutosFarmacêuticos, MMOptics Ltd, Global Healthcare Solutions Perú, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/photodynamic-therapy-global-market-report

Which Region Is Forecasted To Lead The Photodynamic Therapy Market In The Coming Years?

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=5246&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model